Searchable abstracts of presentations at key conferences in endocrinology

ea0021p409 | Thyroid | SFEBES2009

Screening of six novel candidate genes for association with Graves' disease

Tisdall Ruth , Simmonds Matthew , Newby Paul , Franklyn Jayne , Gough Stephen , Brand Oliver

Genome wide association screening (GWAS) has proved invaluable in determining otherwise undetected genetic effects for several common endocrine diseases. The largest GWAS performed in Graves’ disease (GD), to date, has not only confirmed association of several known gene regions, including the HLA region, TSHR and FCRL3, but has also identified several other possible regions of association with GD. As GD shares several susceptibility loci with other endocrin...

ea0015p174 | Endocrine tumours and neoplasia | SFEBES2008

A new pathway in the induction of breast cancer

Watkins Rachel , Smith Vicki , Read Martin , Vasilopoulou Elisavet , James Sally , Boelaert Kristien , Franklyn Jayne , McCabe Christopher

Pituitary tumor transforming gene (PTTG) is a multifunctional oncogene implicated in the pathogenesis of pituitary and thyroid tumours. In breast cancer, PTTG expression is a prognostic marker for lymph node invasion and tumour recurrence. PTTG expression is regulated in vitro and in vivo by oestrogen treatment. PTTG binding factor (PBF) is also a transforming gene, and was isolated due to its functional interaction with PTTG. In the current study, we examined PB...

ea0015p178 | Endocrine tumours and neoplasia | SFEBES2008

A novel mechanism of NIS repression in differentiated thyroid cancer

Smith Vicki , Read Martin , Watkins Rachel , Turnell Andrew , James Sally , Boelaert Kristien , Franklyn Jayne , McCabe Christopher

The ability of the thyroid to accumulate iodide provides the basis for radioiodine ablation of differentiated thyroid cancers and their metastases. Most differentiated thyroid tumours exhibit reduced iodide uptake, however, and the mechanisms accounting for this remain poorly understood. Pituitary tumor transforming gene (PTTG) is a proto-oncogene implicated in the pathogenesis of thyroid tumours. We recently reported that PTTG and its binding factor PBF, also a potent transfo...

ea0015p348 | Thyroid | SFEBES2008

Expression of thyroid hormone transporters in human placenta and changes with intrauterine growth restriction (IUGR)

Chan Shiao , Loubiere Laurence , Vasilopoulou Elisavet , McCabe Christopher , Franklyn Jayne , Kilby Mark

Thyroid hormones (TH) are important for the development of the fetus and placenta. We have previously reported increased placental expression of the potent TH transporter, MCT8, with advancing gestation. The amino acid plasma membrane transporters, MCT10, LAT1, LAT2, and the organic anion transporters, OATP1A2 and OATP4A1, are also known to transport TH.Objective: To describe the ontogeny of these TH transporters and the obligate heterodimer of the LATs,...

ea0015p379 | Thyroid | SFEBES2008

Does the PTPN2 gene exhibit disease specific associations for Graves’ disease?

Storrar Joshua , Newby Paul , Heward Joanne , Franklyn Jayne , Gough Stephen , Simmonds Matthew

Recent genome wide screens performed by the Wellcome Trust Case Control Consortium using 500k single nucleotide polymorphisms (SNP) genotyping arrays have detected several novel susceptibility loci for the common autoimmune diseases (AIDs): Crohn’s disease (CD), type 1 diabetes (T1D) and rheumatoid arthritis (RA). PTPN2, which encodes TCPTP an important negative regulator of inflammation, is one such locus. The rs2542151 SNP in PTPN2 was shown to be highly a...

ea0015p385 | Thyroid | SFEBES2008

Risk of co-existing autoimmune diseases in 3309 index cases with auto-immune thyroid disease and their relatives

Boelaert Kristien , Newby Paul , Simmonds Matthew , Carr-Smith Jackie , Heward Joanne , Gough Stephen , Franklyn Jayne

Autoimmune thyroid diseases (AITD), Graves’ disease (GD) and Hashimoto’s thyroiditis (HT) are common, but there is limited information on the prevalence of co-existing auto-immune diseases (AID). We prospectively collected 3309 patients with AITD and determined prevalences of other autoimmune diseases in index cases and relatives. Overall, 10.3% of 2806 GD patients and 18.1% of 503 HT subjects reported a co-existing AID. Rheumatoid arthritis was the commonest AID in ...

ea0013oc33 | Society for Endocrinology/Clinical Endocrinology Trust Young Investigator Clinical Prize winner | SFEBES2007

Tag SNP screening of the PDCD1 gene for association with Graves’ disease

Newby Paul , Roberts-Davies Emma , Brand Oliver , Heward Joanne , Franklyn Jayne , Gough Stephen , Simmonds Matthew

In addition to the HLA gene region, two further genes involved in the inhibition of T cell signalling, CTLA-4 and PTPN22, have been consistently associated with autoimmune disease (AID), highlighting the important role played by molecules in this pathway in AID susceptibility. The Programmed Cell Death 1 gene (PDCD1) on chromosome 2q37.3 encodes PD-1 which is involved in providing a negative signal to activated T cells. Large case-control studies have show...

ea0013oc34 | British Thyroid Association Award | SFEBES2007

Monocarboxylate transporter 8 (MCT8) represses proliferation of fetal embryonal NT2 and placental JEG-3 cells in vitro

James Sally , McCabe Christopher , Reaves Barbara , Smith Vicki , Chan Shiao , Barrett Timothy , Kilby Mark , Franklyn Jayne

Thyroid hormones play vital roles in fetal brain development. Mutations in MCT8, recently recognised as a specific thyroid hormone transporter, define a novel syndrome of severe X-linked psychomotor retardation and thyroid hormone resistance.N-TERA-2 (NT2) cells (human embryonal cells with characteristics of CNS precursors) were transiently transfected with either WT MCT8 or its L471P, R271H or S448X mutations, described in males affected by severe psych...

ea0013p213 | AMEND Young Investigator's Award | SFEBES2007

The sodium iodide symporter (NIS) is repressed by PTTG via the human NIS upstream enhancer (hNUE)

Smith Vicki , Boelaert Kristien , Stratford Anna , James Sally , Kogai Takahiko , Franklyn Jayne , Mccabe Chris

The sodium iodide symporter (NIS) mediates the uptake of iodide into thyroid follicular cells. The pituitary tumor transforming gene (PTTG) is a multifunctional oncogene which stimulates expression of fibroblast growth factor-2 (FGF-2) via PTTG binding factor (PBF). PTTG and FGF-2 inhibit iodide uptake in rat thyroid FRTL5 cells and PTTG and PBF repress NIS mRNA expression and iodide uptake in primary human thyroid cultures. To determine whether this regulation is a direct tra...

ea0013p325 | Thyroid | SFEBES2007

Preliminary evidence for association of PTPN12 with Graves’ ophthalmopathy

Brand Oliver J , Syed Ateeq A , Franklyn Jayne A , Gough Stephen CL , Heward Joanne M , Simmonds Matthew J

Protein tyrosine phosphatases (PTPs) such as PTPN22, that encodes lymphoid tyrosine phosphatase (LYP), are important regulators of cell signalling. LYP, through interaction with various accessory molecules including Grb2 and Csk kinase, has been shown to be particularly important in regulating signal transduction from the T cell receptor. The identification of PTPN22 as a susceptibility locus for Graves’ disease (GD) led us to hypothesise that other PTPs may...